Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT03650491

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan

NCT02272803

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Aomori, Japan
  • Local Institution Chiba, Japan
View all 28 locations
View Trial Details
Completed

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

NCT01239797

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Northwest Alabama Cancer Center, Pc Muscle Shoals, Alabama, United States
  • Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Local Institution Berkeley, California, United States
  • Local Institution Burbank, California, United States
View all 216 locations
View Trial Details

Related conditions